Connect Biopharma Holdings CNTB
NASDAQ CNTB
$0.75 -0.05 (-5.66%)
As of: Oct 22, 2026 · 10:57 AM EDT

Connect Biopharma Holdings (CNTB) Current Deferred Revenue (2023 - 2025)

Updated

Connect Biopharma Holdings' Current Deferred Revenue was $167,000 in Q4 2025, up 1.8% from $164,000 a year earlier and up 1.2% from the prior quarter.

Analysis

Connect Biopharma Holdings (CNTB) Current Deferred Revenue (2023 - 2025) Analysis & Trends

From Q4 2023 onward, Connect Biopharma Holdings has reported Current Deferred Revenue for 6 quarters.

  • In earlier years, Current Deferred Revenue was $164,000 in FY2024 (-98.8%) and $13.32 million in FY2023.
  • The Q4 2025 figure marks the highest quarterly Current Deferred Revenue since Q4 2023.
  • Per Business Quant data, CNTB's Current Deferred Revenue in the three quarters before Q4 2025 was $165,000 (Q3 2025), $164,000 (Q2 2025) and $164,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn
10 Connect Biopharma Holdings 48.40 Mn -128.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 167,000.00
Sep 30, 2025 165,000.00
Jun 30, 2025 164,000.00
Mar 31, 2025 164,000.00
Dec 31, 2024 164,000.00
Dec 31, 2023 13.32 Mn
API Access

Connect Biopharma Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CNTB&period=max&api_key=YOUR_API_KEY